213 related articles for article (PubMed ID: 33769475)
1. Relative risk of arterial and venous thromboembolism in persons with cancer vs. persons without cancer-a nationwide analysis.
Grilz E; Posch F; Nopp S; Königsbrügge O; Lang IM; Klimek P; Thurner S; Pabinger I; Ay C
Eur Heart J; 2021 Jun; 42(23):2299-2307. PubMed ID: 33769475
[TBL] [Abstract][Full Text] [Related]
2. Risk factors of arterial thrombotic events after unprovoked venous thromboembolism, and after cancer associated venous thromboembolism: A prospective cohort study.
Noumegni SR; Didier R; Mansourati V; Tromeur C; Le Moigne E; Hoffmann C; Nasr B; Gentric JC; Guegan M; Poulhazan E; Lacut K; Bressollette L; Le Mao R; Couturaud F
Thromb Res; 2022 Jun; 214():93-105. PubMed ID: 35525202
[TBL] [Abstract][Full Text] [Related]
3. High Incidence of Arterial and Venous Thrombosis in Antineutrophil Cytoplasmic Antibody-associated Vasculitis.
Kang A; Antonelou M; Wong NL; Tanna A; Arulkumaran N; Tam FWK; Pusey CD
J Rheumatol; 2019 Mar; 46(3):285-293. PubMed ID: 30385704
[TBL] [Abstract][Full Text] [Related]
4. Risk of thromboembolism in patients with multiple myeloma treated with daratumumab: a systemic review and meta-analysis.
Wang J; Kim Y
Int J Hematol; 2020 Nov; 112(5):650-657. PubMed ID: 32710431
[TBL] [Abstract][Full Text] [Related]
5. Bevacizumab Use and the Risk of Arterial and Venous Thromboembolism in Patients with High-Grade Gliomas: A Nested Case-Control Study.
Lee I; Adimadhyam S; Nutescu EA; Zhou J; Asfaw AA; Sweiss KI; Patel PR; Calip GS
Pharmacotherapy; 2019 Sep; 39(9):921-928. PubMed ID: 31332810
[TBL] [Abstract][Full Text] [Related]
6. The CoVID-TE risk assessment model for venous thromboembolism in hospitalized patients with cancer and COVID-19.
Li A; Kuderer NM; Hsu CY; Shyr Y; Warner JL; Shah DP; Kumar V; Shah S; Kulkarni AA; Fu J; Gulati S; Zon RL; Li M; Desai A; Egan PC; Bakouny Z; Kc D; Hwang C; Akpan IJ; McKay RR; Girard J; Schmidt AL; Halmos B; Thompson MA; Patel JM; Pennell NA; Peters S; Elshoury A; de Lima Lopes G; Stover DG; Grivas P; Rini BI; Painter CA; Mishra S; Connors JM; Lyman GH; Rosovsky RP;
J Thromb Haemost; 2021 Oct; 19(10):2522-2532. PubMed ID: 34260813
[TBL] [Abstract][Full Text] [Related]
7. Impact of venous thromboembolism on incidence of arterial thromboembolism - An analysis of German outpatient claims data.
Keller K; Kohring C; Farmakis IT; Valerio L; Barco S; Bätzing J; Akmatov MK; Konstantinides S; Münzel T; Hobohm L; Holstiege J
Thromb Res; 2023 Jun; 226():9-17. PubMed ID: 37079980
[TBL] [Abstract][Full Text] [Related]
8. A nationwide family study of venous thromboembolism and risk of arterial vascular disease.
Zöller B; Li X; Sundquist J; Sundquist K
Heart; 2016 Aug; 102(16):1315-21. PubMed ID: 27048773
[TBL] [Abstract][Full Text] [Related]
9. National survey of confirmed thromboembolism related to female hormones in Japan.
Sugiura K; Kobayashi T; Ojima T
J Obstet Gynaecol Res; 2020 Jul; 46(7):1173-1182. PubMed ID: 32452142
[TBL] [Abstract][Full Text] [Related]
10. Recurrent thrombosis in patients with antiphospholipid antibodies and an initial venous or arterial thromboembolic event: A systematic review and meta-analysis.
Ortel TL; Meleth S; Catellier D; Crowther M; Erkan D; Fortin PR; Garcia D; Haywood N; Kosinski AS; Levine SR; Phillips MJ; Whitehead N
J Thromb Haemost; 2020 Sep; 18(9):2274-2286. PubMed ID: 32484606
[TBL] [Abstract][Full Text] [Related]
11. Impact of antiphospholipid antibodies on thrombotic events in ambulatory cancer patients.
Kansuttiviwat C; Niprapan P; Tantiworawit A; Norasetthada L; Rattarittamrong E; Rattanathammethee T; Hantrakool S; Piriyakhuntorn P; Punnachet T; Hantrakun N; Chai-Adisaksopha C
PLoS One; 2023; 18(1):e0279450. PubMed ID: 36662720
[TBL] [Abstract][Full Text] [Related]
12. Association of total cholesterol variability with risk of venous thromboembolism: A nationwide cohort study.
Park H; Chang Y; Lee H; Hong I; Song TJ
PLoS One; 2023; 18(8):e0289743. PubMed ID: 37590192
[TBL] [Abstract][Full Text] [Related]
13. Relation of Venous Thromboembolism Risk to Ischemic Stroke Risk in Hospitalized Patients with Cancer.
Corley AM; Sullivan MJ; Friedman SE; O'Rourke DJ; Palac RT; Gemignani AS
Am J Cardiol; 2019 Feb; 123(4):679-683. PubMed ID: 30528279
[TBL] [Abstract][Full Text] [Related]
14. Effect of testing for cancer on cancer- and venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE.
Robertson L; Yeoh SE; Stansby G; Agarwal R
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD010837. PubMed ID: 28832905
[TBL] [Abstract][Full Text] [Related]
15. Incidence, risk factors, and outcomes of venous and arterial thromboembolism in immune checkpoint inhibitor therapy.
Moik F; Chan WE; Wiedemann S; Hoeller C; Tuchmann F; Aretin MB; Fuereder T; Zöchbauer-Müller S; Preusser M; Pabinger I; Ay C
Blood; 2021 Mar; 137(12):1669-1678. PubMed ID: 33067632
[TBL] [Abstract][Full Text] [Related]
16. Venous and Arterial Thromboembolism in Patients with Metastatic Lung Cancer.
Qin Y; Zhang L; Liang X; Sun X; Wang N; Yuan M; Wang Q; Wu D
Clin Appl Thromb Hemost; 2023; 29():10760296231159121. PubMed ID: 36814378
[TBL] [Abstract][Full Text] [Related]
17. Hospital-associated venous thromboembolism in children: incidence and clinical characteristics.
Takemoto CM; Sohi S; Desai K; Bharaj R; Khanna A; McFarland S; Klaus S; Irshad A; Goldenberg NA; Strouse JJ; Streiff MB
J Pediatr; 2014 Feb; 164(2):332-8. PubMed ID: 24332452
[TBL] [Abstract][Full Text] [Related]
18. Active tuberculosis and venous thromboembolism: association according to international classification of diseases, ninth revision hospital discharge diagnosis codes.
Dentan C; Epaulard O; Seynaeve D; Genty C; Bosson JL
Clin Infect Dis; 2014 Feb; 58(4):495-501. PubMed ID: 24280089
[TBL] [Abstract][Full Text] [Related]
19. Risk Factors for Postdischarge Major Thromboembolism and Mortality in Hospitalized Patients with COVID-19 with Cardiovascular Comorbidities: Insights from the CORE-19 Registry.
Giannis D; Goldin M; Rahman H; Sison CP; Lesser ML; Ngu S; Tsang J; Qiu M; Sanghani S; Yeh J; Matsagkas M; Arnaoutoglou E; Spyropoulos AC
Thromb Haemost; 2023 Nov; 123(11):1089-1099. PubMed ID: 37146648
[TBL] [Abstract][Full Text] [Related]
20. Increased risk of venous and arterial thromboembolism in patients with colorectal cancer receiving cetuximab-based combination chemotherapy: A population-based study in Korea.
Yhim HY; Lee J; Kim KH; Kim SA; Lee JY; Hwang HG; Hong J; Lee JO; Bang SM
Thromb Res; 2023 Nov; 231():50-57. PubMed ID: 37804738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
